Flavr Savr finally gets its day

In a surprise move, the FDA has scheduled a meeting of its Food Advisory Committee on March 9 and 10 to discuss the safety of biotechnology-based whole foods. Calgene Inc.'s Flavr Savr tomato will serve as the focus of the meeting, at which CGNE will present a summary of its data on the food product.

The FDA's decision to conduct an advisory panel meeting caught the Davis, Calif.-based company unawares. "As of five days ago, it wasn't on any of the time-action plans we discussed with the FDA," said Chairman and CEO Roger Salquist